Details for New Drug Application (NDA): 213126
✉ Email this page to a colleague
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
Summary for 213126
Tradename: | CHLORZOXAZONE |
Applicant: | Rising |
Ingredient: | chlorzoxazone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 213126
Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for 213126
Suppliers and Packaging for NDA: 213126
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 213126 | ANDA | Rising Pharma Holdings, Inc. | 16571-725 | 16571-725-01 | 100 TABLET in 1 BOTTLE (16571-725-01) |
CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 213126 | ANDA | Rising Pharma Holdings, Inc. | 16571-725 | 16571-725-50 | 500 TABLET in 1 BOTTLE (16571-725-50) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 375MG | ||||
Approval Date: | Apr 5, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Apr 5, 2022 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 750MG | ||||
Approval Date: | Apr 5, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription